Bonesupport
371.8
SEK
+0.81 %
BONEX
NASDAQ Stockholm
Medical Equipment & Services
Health Care
9 following
+0.81%
+9.35%
+26.03%
+43.89%
+97.56%
+125.33%
+927.07%
+1,009.85%
+1,061.88%
www.bonesupport.com/en-eu/investors
Bone Support is active in medical technology. The company develops and commercializes injectable bioceramic bone graft substitutes that are transformed into the patient's bone and have the ability to release drugs. The company's bone graft substitutes are based on the technology platform Cerament. At present, the company conducts ongoing clinical studies. The company has sales in Europe and North America and is headquartered in Lund, Sweden.
Revenue
591.08M
EBIT %
2.36 %
P/E
98.62
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
BONEX
Daily low / high price
365 / 372.2
SEK
Market cap
24.82B SEK
Turnover
19.47M SEK
Volume
53K
Latest videos
Financial calendar
Annual report
25.02.2025
Interim report
24.04.2025
Interim report
15.07.2025
Interim report
23.10.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
HealthCap | 9.9 % | 10.0 % |
Swedbank Robur Fonder | 9.0 % | 9.1 % |
Capital Group | 7.9 % | 8.0 % |
Handelsbanken Fonder | 4.1 % | 4.1 % |
Avanza Pension | 3.7 % | 3.7 % |
Norges Bank | 2.5 % | 2.5 % |
JP Morgan Asset Management | 2.4 % | 2.4 % |
SEB Investment Management | 2.0 % | 2.0 % |
Tredje AP-Fonden | 1.9 % | 1.9 % |
Erik Selin | 1.7 % | 1.7 % |
ShowingAll content types
Announced Insider Trading
Redeye: BONESUPPORT Q3 - Surprising on US sales and EBIT
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools